Activation of Flk-1/KDR mediates angiogenesis but not hypotension

Cardiovascular Research

Volumn 36, Issue 2, 1997, Pages 276-281

  Malavaud, Bernard ^a,b   Tack, Ivan ^c   Jonca, Frédéric ^a,b   Praddaude, Françoise ^c   Moro, Françoise ^a   Ader, Jean Louis ^c   Plouët, Jean ^a  

^a CNRS   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c INSERM   (France)

Author keywords

Angiogenesis; Blood pressure; Flk 1 KDR; Flt 1; Nitric oxide; Rabbit; Vascular endothelial growth factor; Wistar Kyoto rat

Indexed keywords

NITRIC OXIDE SYNTHASE; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HEMODYNAMICS; HORMONE ACTION; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SPECIES DIFFERENCE;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; BLOOD PRESSURE; CORNEA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; LYMPHOKINES; MALE; NEOVASCULARIZATION, PATHOLOGIC; OMEGA-N-METHYLARGININE; RABBITS; RATS; RATS, INBRED WKY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; STATISTICS, NONPARAMETRIC; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031282098     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00177-6     Document Type: Article

References (26)

1. Baffour R., Berman J., Garb J.L., See S.W., Kaufman J., Friedman P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose response effect of basic fibroblast growth factor. J Vasc Surg. 16:1992;181-191.
2. Bauters C., Asahara T., Zheng L.P., Takeshita S., Bunting S., Ferrara N., Symes J.F., Isner J.M. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg. 21:1995;314-325.
3. Takeshita S., Zheng L.P., Brogi E., Kearney M., Pu L.Q., Bunting S., Ferrara N., Symes J.F., Isner J.M. Therapeutic angiogenesis. J Clin Invest. 93:1994;662-670.
4. Walder C.E., Errett C.J., Bunting S., Linquist P., Ogez J.R., Heinsohn H.G., Ferrara N., Thomas G.R. Vascular endothelial growth factor augments muscle blood flow and function in a rabbit model of chronic hindlimb ischemia. J Cardiovascular Res. 27:1996;91-98.
5. Takeshita S., Weir L., Chen D., Zheng L.P., Riessen R., Bauters C., Symes J.F., Ferrara N., Isner J.M. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem Biophys Res Commun. 227:1996;628-635.
6. Plouët J., Shilling J., Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J. 3:1989;3801-3806.
7. Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H., Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 5:1990;519-524.
8. Terman B.I., Vermazen M.D., Carrion M.E., Dimitrov D., Armellino D.C., Gospodarowicz D., Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun. 187:1992;1579-1586.
9. Isner J.M., Pieczek A., Schainfeld R., Blair R., Haley L., Asahara T., Rosenfield K., Razvi S., Walsh K., Symes J.F. Clinical evidence of angiogenesis after arterial gene transfer of ph VEGF165 in patients with ischaemic limb. Lancet. 348:1996;370-374.
10. Li J., Brown L.F., Hibberd M.G., Grossman J.D., Morgan J.P., Simons M. VEGF, flk-1 and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol. 270:1996;H1803-H1811. (Heart Circ Physiol 39).
11. Harada K., Friedman M., Lopez J.J., Wang S.Y., Li J., Pottumarthi V.P., Pearlman J.D., Edelman E.R., Sellke F.W., Simons M. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol. 270:1996;H1791-H1802. (Heart Circ Physiol 39).
12. Banai S., Jaklitsch M.T., Shou M., Lazarous M., Scheinowitz M., Biro S., Epstein E., Unger E.F. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 89:1994;2183-2189.
13. Hariawala M.D., Horowitz J.R., Esakof D., Sheriff D.D., Walter D.H., Keyt B., Isner J.M., Symes J.F. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res. 63:1996;77-82.
14. Fiebich B., Jager B., Schollmann C., Weindel K., Wilting J., Kochs G., Marme D., Hug H., Weich H.A. Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells. Eur J Biochem. 211:1993;19-26.
15. Guerrin M., Moukadiri H., Chollet P., Moro F., Dutt K., Malecaze F., Plouët J. Vasculotropin/Vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol. 164:1995;385-394.
16. Ortega N., Jonca F., Vincent S., Favard C., Malavaud B., Bertrand N., Mazerolles C., Rischmann P., Pouliquen Y., Sarramon J.P., Ruchoux M.M., Plouët J. Modulation of tumor progression by anti-idiotypic antibodies of angiogenic factors. C R Acad Sci Paris. 319:1996;411-415.
17. Favard C., Moukadiri H., Dorey C., Praloran V., Plouët J. Purification and biological properties of vasculotropin, a new angiogenic cytokine. Biol Cell. 73:1991;1-6.
18. Whittle B.J.R., Lopez-Belmonte J., Rees D.D. Modulation of the vasodepressor actions of acetylcholine, bradykinine, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br J Pharmacol. 98:1989;646-652.
19. Lazarous D.F., Shou M., Scheinowitz M., Hodge E., Thirumurti V., Kitsiou A., Stiber J.A., Lobo A.D., Hunsberger S., Guetta E., Epstein S.E., Unger E.F. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation. 94:1996;1074-1082.
20. Harada K., Grossman W., Friedman M., Edelman E.R., Pradad P.V., Keighley C.S., Manning W.J., Sellke F.W., Simons M. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest. 94:1994;623-630.
21. Bérard M., Sordello S., Ortéga N., Carrier J.-L., Peyri N., Wassef M., Bertrand N., Enjolras O., Drouet L., Plouët J. Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. Am J Pathol. 150:1997;1315-1326.
22. Yang R., Thomas R., Bunting S., Ko A., Ferrara N., Keyt B., Ross J., Jin H. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol. 27:1996;838-844.
23. Symes J.F., Sniderman A.D. Angiogenesis: potential therapy for ischaemic disease. Curr Opin Lipidol. 5:1994;305-312.
24. Burke P., Lehmann-Bruinsma K., Powell J.S. Vascular endothelial growth factor causes endothelial proliferation after vascular injury. Biochem Biophys Res Comm. 207:1995;348-354.
25. Ku D.D., Zaleski J.H., Liu S., Brock T.A. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol. 265:1993;H586-H592. (Heart Circ. Physiol. 34).
26. Keyt B.A., Nguyen H.V., Berleau L.T., Duarte C.M., Park J., Chen H., Ferrara N. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. J Biol Chem. 271:1996;5638-5646.